Six-Month Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: A Multicenter Clinical Study in High-Risk Surgical Patients
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Co-Founder and Co-Inventor Cephea Valve Technologies (Abbott) - Abbott